Newbury Park, CA, United States of America

Kexue Li

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 8.8

ph-index = 5

Forward Citations = 43(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2007)
  • Mountain View, CA (US) (2007 - 2015)
  • Thousand Oaks, CA (US) (2020 - 2022)
  • Newbury Park, CA (US) (2019 - 2024)

Company Filing History:


Years Active: 2007-2025

where 'Filed Patents' based on already Granted Patents

18 patents (USPTO):

Title: Kexue Li: Innovator in Cancer Treatment

Introduction

Kexue Li is a prominent inventor based in Newbury Park, California, known for his significant contributions to the field of cancer research. With a total of 18 patents to his name, he has made remarkable strides in developing innovative treatments for cancer and cancer-related diseases.

Latest Patents

Among his latest patents are the KIF18A inhibitors, which include compounds capable of modulating the KIF18A protein. This modulation influences the processes of cell cycle and cell proliferation, providing potential therapeutic avenues for treating cancer. The invention encompasses pharmaceutical compositions that include these compounds and methods for treating disease states related to KIF18A activity.

Career Highlights

Kexue Li has had a distinguished career, working with notable companies such as Amgen Inc. and Japan Tobacco Inc. His work has been pivotal in advancing cancer treatment methodologies, showcasing his dedication to improving patient outcomes through innovative research.

Collaborations

Throughout his career, Kexue Li has collaborated with various professionals in the field, including Sean P Brown and Yunxiao Li, who is a woman. These collaborations have further enriched his research and development efforts.

Conclusion

Kexue Li's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a leading inventor in the medical field. His work continues to inspire advancements in cancer therapies and improve the lives of many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…